| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 0.00 | £ 0.00 | £ 587.00K | £ 542.00K | £ 219.00K |
| Gross Profit | £ 0.00 | £ 0.00 | £ -134.00K | £ -51.00K | £ 55.00K |
| Operating Income | £ -3.48M | £ -1.38M | £ -3.12M | £ -2.71M | £ -845.00K |
| EBITDA | £ -5.74M | £ -1.38M | £ -2.94M | £ -2.59M | £ -900.00K |
| Net Income | £ -5.74M | £ -1.59M | £ -3.12M | £ -2.71M | £ -954.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 1.72M | £ 757.00K | £ 155.00K | £ 1.64M | £ 598.00K |
| Total Assets | £ 7.58M | £ 3.20M | £ 2.43M | £ 4.94M | £ 3.13M |
| Total Debt | £ 75.00K | £ 0.00 | £ 34.00K | £ 22.00K | £ 950.00K |
| Net Debt | £ -1.65M | £ -757.00K | £ -121.00K | £ -1.62M | £ 352.00K |
| Total Liabilities | £ 1.39M | £ 119.00K | £ 408.00K | £ 385.00K | £ 2.32M |
| Stockholders' Equity | £ 6.19M | £ 3.08M | £ 2.03M | £ 4.55M | £ 812.00K |
| Cash Flow | |||||
| Free Cash Flow | £ -3.27M | £ -1.13M | £ -1.47M | £ -3.08M | £ -255.00K |
| Operating Cash Flow | £ -3.27M | £ -1.13M | £ -1.24M | £ -2.36M | £ -254.00K |
| Investing Cash Flow | £ 0.00 | £ -337.00K | £ -232.00K | £ -718.00K | £ -1.00K |
| Financing Cash Flow | £ 4.23M | £ 2.08M | £ 0.00 | £ 4.13M | £ 800.00K |
Solvonis Therapeutics (DE:J4I)
FRANKFURT:J4I
